+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 5Years - 15Years
All Genders
ID07884773

Evaluating Safety and Effectiveness of Danazol, Prednisolone, and Thalidomide Combination Versus Thalidomide Alone in Children with Transfusion-Dependent Beta-Thalassemia

Led by Khyber Medical University Peshawar · Updated on 2026-10-21

172

Participants Needed

1

Research Sites

5 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate treatments for children aged 5 to 15 years with transfusion-dependent beta-thalassemia major who have not responded well to thalidomide therapy. The study compares thalidomide alone versus a combination of thalidomide, danazol, and prednisolone to see if the combination reduces blood transfusion needs, increases hemoglobin levels, and is safe. About 172 children will be randomly assigned to one of the two treatment groups and followed for 9 to 12 months. Participants will receive either thalidomide alone, with the dose adjusted every 2 to 4 weeks based on response, or a combination of thalidomide plus danazol and prednisolone. Danazol is taken orally three times daily for 30-day cycles, and prednisolone is given twice daily for 10 days each month. Supportive care with famotidine, folic acid, and vitamin B12 is also provided in the combination group. Both treatments last between 9 and 12 months. During the study, participants will be monitored regularly with assessments at months 1, 3, 6, 9, and the final visit. Researchers will check for transfusion independence, hemoglobin levels, and safety using standard criteria. Secondary outcomes include measuring transfusion burden, blood health improvements, quality of life, and genetic factors related to treatment response. The study involves blood tests, clinical evaluations, and tracking of side effects over the follow-up period.

CONDITIONS

Brief Title

Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia

Research Team

S

Syeda Nayab Imtiaz, MBBS

G

Gulab Fatima Rani, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here